131 related articles for article (PubMed ID: 17284619)
21. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
22. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas.
Samowitz WS; Powers MD; Spirio LN; Nollet F; van Roy F; Slattery ML
Cancer Res; 1999 Apr; 59(7):1442-4. PubMed ID: 10197610
[TBL] [Abstract][Full Text] [Related]
23. Activating mutations in CTNNB1 in aldosterone producing adenomas.
Åkerström T; Maharjan R; Sven Willenberg H; Cupisti K; Ip J; Moser A; Stålberg P; Robinson B; Alexander Iwen K; Dralle H; Walz MK; Lehnert H; Sidhu S; Gomez-Sanchez C; Hellman P; Björklund P
Sci Rep; 2016 Jan; 6():19546. PubMed ID: 26815163
[TBL] [Abstract][Full Text] [Related]
24. Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.
Tadjine M; Lampron A; Ouadi L; Bourdeau I
Clin Endocrinol (Oxf); 2008 Feb; 68(2):264-70. PubMed ID: 17854394
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
Wagner PL; Chen YT; Yantiss RK
Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
[TBL] [Abstract][Full Text] [Related]
26. Nuclear β-catenin expression in basal cell adenomas of salivary gland.
Kawahara A; Harada H; Abe H; Yamaguchi T; Taira T; Nakashima K; Mihashi H; Akiba J; Kage M
J Oral Pathol Med; 2011 Jul; 40(6):460-6. PubMed ID: 21323741
[TBL] [Abstract][Full Text] [Related]
27. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
Lazar AJ; Tuvin D; Hajibashi S; Habeeb S; Bolshakov S; Mayordomo-Aranda E; Warneke CL; Lopez-Terrada D; Pollock RE; Lev D
Am J Pathol; 2008 Nov; 173(5):1518-27. PubMed ID: 18832571
[TBL] [Abstract][Full Text] [Related]
28. Absence of p53 point mutations in parathyroid adenoma and carcinoma.
Hakim JP; Levine MA
J Clin Endocrinol Metab; 1994 Jan; 78(1):103-6. PubMed ID: 8288693
[TBL] [Abstract][Full Text] [Related]
29. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
30. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
31. Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.
Jo VY; Sholl LM; Krane JF
Am J Surg Pathol; 2016 Aug; 40(8):1143-50. PubMed ID: 27259009
[TBL] [Abstract][Full Text] [Related]
32. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
33. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.
Ueda Y; Hiyama E; Kamimatsuse A; Kamei N; Ogura K; Sueda T
J Pediatr Surg; 2011 Dec; 46(12):2221-7. PubMed ID: 22152854
[TBL] [Abstract][Full Text] [Related]
34. Genetic abnormalities in sporadic parathyroid adenomas.
Friedman E; Bale AE; Marx SJ; Norton JA; Arnold A; Tu T; Aurbach GD; Spiegel AM
J Clin Endocrinol Metab; 1990 Aug; 71(2):293-7. PubMed ID: 2199477
[TBL] [Abstract][Full Text] [Related]
35. Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas.
Costa-Guda J; Soong CP; Parekh VI; Agarwal SK; Arnold A
Horm Cancer; 2013 Oct; 4(5):301-7. PubMed ID: 23715670
[TBL] [Abstract][Full Text] [Related]
36. Mutations in exon 3 of the CTNNB1 gene (beta-catenin gene) in cutaneous adnexal tumors.
Kazakov DV; Sima R; Vanecek T; Kutzner H; Palmedo G; Kacerovska D; Grossmann P; Michal M
Am J Dermatopathol; 2009 May; 31(3):248-55. PubMed ID: 19384065
[TBL] [Abstract][Full Text] [Related]
37. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.
Björklund P; Akerström G; Westin G
PLoS Med; 2007 Nov; 4(11):e328. PubMed ID: 18044981
[TBL] [Abstract][Full Text] [Related]
38. p53 abnormalities in human parathyroid carcinoma.
Cryns VL; Rubio MP; Thor AD; Louis DN; Arnold A
J Clin Endocrinol Metab; 1994 Jun; 78(6):1320-4. PubMed ID: 8200932
[TBL] [Abstract][Full Text] [Related]
39. Ruling out a suspect: the role of beta-catenin mutation in benign parathyroid neoplasia.
Simonds WF
J Clin Endocrinol Metab; 2007 Apr; 92(4):1235-6. PubMed ID: 17409343
[No Abstract] [Full Text] [Related]
40. A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.
Guarnieri V; Baorda F; Battista C; Bisceglia M; Balsamo T; Gruppioni E; Fiorentino M; Muscarella LA; Coco M; Barbano R; Corbetta S; Spada A; Cole DE; Canaff L; Hendy GN; Carella M; Scillitani A
Endocrine; 2012 Feb; 41(1):152-5. PubMed ID: 22095489
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
